Clearstead Advisors, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Clearstead Advisors, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$309,696
+68.5%
8,206
+103.5%
0.01%
-18.2%
Q2 2023$183,744
-1.7%
4,033
-12.5%
0.01%
-21.4%
Q1 2023$186,991
-23.2%
4,610
-3.5%
0.01%
-26.3%
Q4 2022$243,522
-7.8%
4,778
-2.7%
0.02%
-20.8%
Q3 2022$264,000
-13.2%
4,910
+3.6%
0.02%0.0%
Q2 2022$304,000
-16.9%
4,738
+0.5%
0.02%
-4.0%
Q1 2022$366,000
-16.1%
4,716
-7.2%
0.02%
-16.7%
Q4 2021$436,000
+6.1%
5,083
-0.6%
0.03%
-3.2%
Q3 2021$411,000
-6.4%
5,114
-6.2%
0.03%
-8.8%
Q2 2021$439,000
+0.7%
5,454
+5.4%
0.03%
-5.6%
Q1 2021$436,000
+1.9%
5,174
-3.1%
0.04%
-7.7%
Q4 2020$428,000
-0.9%
5,339
-0.5%
0.04%
-15.2%
Q3 2020$432,000
-4.4%
5,368
+2.2%
0.05%
-11.5%
Q2 2020$452,000
+27.0%
5,255
+19.9%
0.05%0.0%
Q1 2020$356,000
-3.0%
4,3840.0%0.05%
+15.6%
Q4 2019$367,000
-4.2%
4,3840.0%0.04%
-11.8%
Q3 2019$383,000
+6.7%
4,3840.0%0.05%
+6.2%
Q2 2019$359,000
-3.5%
4,384
-4.3%
0.05%
-5.9%
Q1 2019$372,000
+43.6%
4,579
+16.6%
0.05%
+27.5%
Q4 2018$259,000
+21.6%
3,928
+41.9%
0.04%
+37.9%
Q3 2018$213,000
-86.4%
2,768
-88.6%
0.03%
-86.3%
Q4 2017$1,566,000
+3.0%
24,2300.0%0.21%
+7.1%
Q3 2017$1,520,000
+3.6%
24,230
-0.0%
0.20%
-7.5%
Q2 2017$1,467,000
+46.4%
24,239
+25.5%
0.21%
+46.6%
Q1 2017$1,002,000
+12.5%
19,318
-3.9%
0.15%
+1.4%
Q4 2016$891,00020,1040.14%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders